| Bioactivity | Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1]. | ||||||||||||
| Name | Izilendustat | ||||||||||||
| CAS | 1303512-02-8 | ||||||||||||
| Formula | C22H28ClN3O4 | ||||||||||||
| Molar Mass | 433.93 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Joseph H, et al. Prolyl hydroxylase inhibitors. Patent WO2011057115A1. [2]. Joseph H, et al. Compositions and methods for treating colitis. Patent WO2011057121A1. |
Izilendustat
CAS: 1303512-02-8 F: C22H28ClN3O4 W: 433.93
Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.